(R)-4-((2,5-dioxo-3-(pyridin-3-ylmethyl)-2,3-dihydro-1H-benzo[e][1,4]diazepin-4(5H)-yl)methyl)benzoic acid

ID: ALA4210191

PubChem CID: 145963833

Max Phase: Preclinical

Molecular Formula: C23H19N3O4

Molecular Weight: 401.42

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)c1ccc(CN2C(=O)c3ccccc3NC(=O)[C@H]2Cc2cccnc2)cc1

Standard InChI:  InChI=1S/C23H19N3O4/c27-21-20(12-16-4-3-11-24-13-16)26(14-15-7-9-17(10-8-15)23(29)30)22(28)18-5-1-2-6-19(18)25-21/h1-11,13,20H,12,14H2,(H,25,27)(H,29,30)/t20-/m1/s1

Standard InChI Key:  JHONTRULXQQRSP-HXUWFJFHSA-N

Molfile:  

     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
    5.1262   -5.9751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1262   -6.8001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8407   -7.2126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8407   -5.5626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5551   -6.8001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5551   -5.9751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2002   -5.4607    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2002   -7.3145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0045   -5.6443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0045   -7.1309    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.3624   -6.3876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5189   -4.9993    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.0166   -8.1188    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.1874   -6.3876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5999   -7.1021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5189   -7.7759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2174   -8.5439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7318   -9.1889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4304   -9.9569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6146  -10.0798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1003   -9.4348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4017   -8.6669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3132  -10.8478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4974  -10.9708    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.8276  -11.4928    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.4249   -7.1021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8374   -7.8166    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.4249   -8.5310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5999   -8.5310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1874   -7.8166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  5  2  0
  6  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  7  9  1  0
  8 10  1  0
  9 11  1  0
 10 11  1  0
  9 12  2  0
  8 13  2  0
 11 14  1  1
 14 15  1  0
 10 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
 20 23  1  0
 23 24  1  0
 23 25  2  0
 15 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 15  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4210191

    ---

Associated Targets(non-human)

tcdB Toxin B (126 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Clostridioides difficile (2968 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Limosilactobacillus reuteri (118 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bifidobacterium longum (298 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bacteroides fragilis (1445 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 401.42Molecular Weight (Monoisotopic): 401.1376AlogP: 2.99#Rotatable Bonds: 5
Polar Surface Area: 99.60Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 4.01CX Basic pKa: 4.98CX LogP: 2.37CX LogD: 0.23
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.68Np Likeness Score: -0.41

References

1. Letourneau JJ, Stroke IL, Hilbert DW, Sturzenbecker LJ, Marinelli BA, Quintero JG, Sabalski J, Ma L, Diller DJ, Stein PD, Webb ML..  (2018)  Identification and initial optimization of inhibitors of Clostridium difficile (C. difficile) toxin B (TcdB).,  28  (4): [PMID:29331267] [10.1016/j.bmcl.2018.01.005]

Source